drugset / Trial / NCT00624702
Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will explore information on whether changing the salt formulation of indacaterol affects the incidence of post-inhalation cough.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Indacaterol | Other / unclassified | 400 ug | Inhaled |